Retour sur lavenir.net
   ECONOCOM GROUP 1.500 € (+1,35 %)     CMB.TECH 12.580 € (+1,13 %)     KINEPOLIS GROUP 36.000 € (-0,96 %)     AB INBEV 73.420 € (-0,14 %)     COFINIMMO 83.000 € (-1,66 %)     UCB 265.800 € (+0,87 %)     SOLVAY 26.440 € (-0,15 %)     ONTEX GROUP 2.470 € (-1,59 %)     AEDIFICA 70.400 € (-1,88 %)     SOFINA 223.200 € (+0,63 %)     ARGENX SE 812.400 € (+3,44 %)     CENERGY 23.220 € (+0,17 %)     KBC 118.800 € (+0,93 %)     OPTION 5.840 € (+3,18 %)     XIOR 26.450 € (-0,56 %)     PROXIMUS 5.915 € (-0,84 %)     TINC 11.460 € (+1,42 %)     KBC ANCORA 82.100 € (+1,23 %)     SYENSQO 65.550 € (+1,55 %)     RECTICEL 11.040 € (+1,28 %)     TUBIZE-FIN 232.600 € (+1,04 %)     WDP 22.120 € (+0,18 %)     UMICORE 20.180 € (-1,27 %)     AZELIS GROUP 9.630 € (+0,73 %)     AGEAS 69.850 € (+1,16 %)     GBL 79.950 € (+0,63 %)     ELIA GROUP 140.200 € (+0,57 %)     VASTNED 29.700 € (0,00 %)     D'IETEREN GROUP 168.700 € (-0,41 %)     BARCO 8.400 € (+0,78 %)     BPOST 1.570 € (+1,29 %)     FAGRON 24.200 € (+1,47 %)     LOTUS BAKERIES 11 740.000 € (+1,91 %)     MELEXIS 78.200 € (+2,16 %)     DEME GROUP 176.800 € (+1,14 %)     RETAIL ESTATES 69.500 € (-1,00 %)     ACKERMANS V.HAAREN 287.200 € (+1,84 %)     BEKAERT 39.000 € (+0,91 %)     AGFA-GEVAERT 0.423 € (-0,59 %)     NYXOAH 1.506 € (+1,21 %)     COLRUYT 36.300 € (+1,62 %)     DECEUNINCK 2.225 € (+1,60 %)     CELYAD ONCOLOGY 0.247 € (+6,47 %)     TESSENDERLO 19.520 € (+0,83 %)     EVS 27.500 € (+0,18 %)     VGP 85.200 € (+1,43 %)     CAMPINE 224.000 € (+9,27 %)     GIMV 46.250 € (+0,76 %)     MONTEA 66.700 € (+1,21 %)     TITAN S.A. 52.000 € (+1,56 %)     IBA 16.980 € (+0,35 %)     BREDERODE 105.400 € (+0,76 %)     FLUXYS BELGIUM D 19.750 € (+2,33 %)     ONWARD MEDICAL 2.560 € (-0,39 %)     SHURGARD 26.050 € (+1,17 %)     BELYSSE GROUP 0.560 € (+1,82 %)     BIOTALYS 3.120 € (+0,32 %)     QUESTFOR GR-PRICAF 2.961 € (-0,30 %)     CFE 13.250 € (-1,12 %)     CARE PROPERTY INV. 12.500 € (-0,32 %)  
   VIRIDIEN 84.400 € (-0,59 %)     FDJ UNITED 21.280 € (-1,16 %)     NICOX 0.378 € (+0,94 %)     EXOSENS 56.250 € (+1,08 %)     TONNER DRONES 0.025 € (-2,76 %)     CVC CAPITAL 12.660 € (+1,28 %)     LOUIS HACHETTE 1.775 € (-0,73 %)     REXEL 38.110 € (+2,17 %)     SAFRAN 344.600 € (+2,41 %)     HEINEKEN 72.720 € (-1,49 %)     EDP 4.595 € (+2,98 %)     KERING 250.500 € (-5,70 %)     ALSTOM 15.240 € (+1,57 %)     EUROFINS SCIENT. 68.440 € (+0,38 %)     LVMH 484.000 € (-1,69 %)     STELLANTIS NV 4.979 € (+1,81 %)     UNILEVER 53.060 € (-0,24 %)     ASML HOLDING 1 676.400 € (+4,00 %)     SOCIETE GENERALE 77.410 € (+0,70 %)     AIRBUS 194.880 € (+1,72 %)     BNP PARIBAS ACT.A 101.540 € (+1,18 %)     NANOBIOTIX 32.580 € (+4,69 %)     THALES 224.200 € (+1,68 %)     PROSUS 38.280 € (-0,27 %)     HYDROGEN REFUELING 1.700 € (-2,19 %)     AIR LIQUIDE 173.540 € (+0,47 %)     ACCOR 50.680 € (+1,08 %)     CAPGEMINI 88.320 € (-2,45 %)     ORANGE 16.685 € (-0,57 %)     BOUYGUES 49.000 € (+0,86 %)     FERMENTALG 0.494 € (-5,10 %)     ING GROEP N.V. 27.495 € (+0,94 %)     BOIRON 27.900 € (-0,36 %)     TELEPERFORMANCE 46.660 € (-10,23 %)     HAFFNER ENERGY 0.225 € (-1,54 %)     J.MARTINS,SGPS 16.860 € (-3,10 %)     ALLFUNDS GROUP 8.450 € (+0,60 %)     CSG 12.916 € (-0,42 %)     MEDIANTECHNOLOGIES 4.680 € (+0,65 %)     TOTALENERGIES 67.850 € (-1,64 %)     BE SEMICONDUCTOR 286.000 € (+2,55 %)     ASM INTERNATIONAL 996.200 € (+2,51 %)     ARCELORMITTAL SA 53.300 € (+3,50 %)     SCHNEIDER ELECTRIC 286.700 € (+3,09 %)     DSM FIRMENICH AG 82.400 € (+0,96 %)     CTT CORREIOS PORT 5.865 € (+0,69 %)     ICADE 19.120 € (-0,62 %)     DASSAULT SYSTEMES 18.025 € (-0,30 %)     WOLTERS KLUWER 56.920 € (+0,11 %)     ARGAN 60.400 € (-0,33 %)     EXOR NV 67.350 € (+0,75 %)     SAINT GOBAIN 79.660 € (+2,73 %)     EUTELSAT COMMUNIC. 2.340 € (+3,95 %)     CREDIT AGRICOLE 17.505 € (+0,34 %)     AKZO NOBEL 59.340 € (+0,41 %)     ESSILORLUXOTTICA 163.700 € (+0,12 %)     MICHELIN 33.790 € (+1,17 %)     ADYEN 829.300 € (+0,04 %)     VEOLIA ENVIRON. 36.340 € (+0,69 %)     SANOFI 75.880 € (+0,50 %)  
News Réglementées
13/03/2023 09:50

JSC Halyk Bank: Consolidated financial results for the year ended 31 December 2022

JSC Halyk Bank (HSBK)
JSC Halyk Bank: Consolidated financial results for the year ended 31 December 2022

13-March-2023 / 08:50 GMT/BST
The issuer is solely responsible for the content of this announcement.


March 13, 2023

 

Joint Stock Company ‘Halyk Savings Bank of Kazakhstan’

Consolidated financial results 

for the year ended 31 December 2022

Joint Stock Company ‘Halyk Savings Bank of Kazakhstan’ and its subsidiaries (together “the Bank”) (LSE: HSBK) releases consolidated financial statements and independent auditors’ report for the year ended 31 December 2022.

 

Consolidated income statements

KZT mln

 

 

12M 2022

12M 2021

Y-o-Y,%

4Q 2022

4Q 2021

Y-o-Y,%

Interest income

1,247,644

879,865

41.8%

360,190

242,490

48.5%

Interest expense

(577,445)

(366,792)

57.4%

(171,203)

(111,126)

54.1%

Net interest income before  credit loss expense

670,199

513,073

30.6%

188,987

131,364

43.9%

Fee and commission income

180,066

138,389

30.1%

51,404

36,639

40.3%

Fee and commission expense

(96,274)

(71,789)

34.1%

(25,309)

(20,015)

26.5%

Net fee and commission income

83,792

66,600

25.8%

26,095

16,624

57.0%

Net insurance income (1)

21,812

43,863

(50.3%)

16,417

13,429

22.3%

Net foreign exchange gain

178,900

30,536

5.9x

48,639

7,541

6.4x

Net (loss)/gain from derivative operations and securities (2)

(4,908)

16,472

(0.3x)

(13,532)

5,665

(2.4x)

Share in profit of associate, income on non-banking activities, other (expense)/income and loss on disposal of subsidiaries

13,854

31,348

(55.8%)

(25,472)

18,057

(1.4x)

(Credit loss expense)/recovery of credit loss expense (3)

(106,778)

4,004

(26.7x)

(12,069)

9,477

(1.3x)

Recovery of other credit loss expense/(other credit loss expense)

78

(4,002)

(101.9%)

528

(369)

(1.4x)

Operating expenses (4)

(198,100)(5)

(177,279)(6)

11.7%

(51,950)(7)

(55,868)(8)

(7.0%)

Income tax expense

(105,097)

(62,237)

68.9%

(40,987)

(16,637)

2.5x

Net profit

553,752

462,378

19.8%

136,656

129,283

5.7%

Non-controlling interest

1

1

-

-

1

(100.0%)

Net profit attributable to common shareholders

553,751

462,377

19.8%

136,656

129,282

5.7%

 

 

 

 

 

 

 

Net interest margin, p.a.

5.6%

5.2%

 

6.0%

5.0%

 

Return on average equity, p.a.

31.7%

29.7%

 

29.1%

31.7%

 

Return on average assets, p.a.

4.1%

4.2%

 

3.8%

4.4%

 

Cost-to-income ratio

19.0%

24.1%

 

19.1%

27.9%

 

Cost of risk on loans to customers, p.a.

1.2%

0.2%

 

0.4%

0.2%

 

 

  1. Insurance underwriting income (gross insurance premiums written, net change in unearned insurance premiums, ceded reinsurance share) less insurance claims incurred and insurance agency commissions (insurance payments, insurance reserves expenses, commissions to agents);
  2. Net (loss)/gain on financial assets and liabilities at fair value through profit or loss and net realised (loss)/gain from financial assets at fair value through other comprehensive income;
  3. Total credit loss expense, including credit loss expense on loans to customers, amounts due from credit institutions, financial assets at FVTOCI, cash and cash equivalents and other assets;
  4. Including loss from impairment of non-financial assets and reversal of impairment loss of property, plant and equipment:
  5. KZT 4.1bn;
  6. KZT -5.8bn;
  7. KZT 4.2bn;
  8. KZT -5.6bn.

 

 

The net profit attributable to common shareholders amounted to KZT 553.8bn in 12M 2022, up 19.8% compared with KZT 462.4bn in 12M 2021 mainly due to significant increase in lending business, including acquisition of Sber’s loan portfolio, as well as increase in net gain on foreign exchange operations and net fee and commission income.

 

The interest income for 12M 2022 increased by 41.8% vs. 12M 2021 mainly due to increase in average rate and balances of loans to customers. The interest expense for 12M 2022 increased by 57.4% vs. 12M 2021 mainly as a result of the growth in average rate and balances of amounts due to customers. Consequently, net interest income for 12M 2022 grew by 30.6% vs. 12M 2021. In 12M 2022, the net interest margin was affected by the increase in average rates on both loans to customers and amounts due to customers following the base rate hike from 10.25% to 16.75% in 12M 2022. Furthermore, the share of loans to customers in total interest-earning assets increased substantially. Moreover, there was an increase in the average rate and average balances of FX amounts due from credit institutions and FX interest-earning cash and cash equivalents following the global increase of USD interest rates. As a result, net interest margin increased to 5.6% p.a. for 12M 2022 compared to 5.2% p.a. for 12M 2021.

 

The cost of risk on loans to customers for 12M 2022 was at 1.2% reflecting more normalized credit loss expenses on corporate and SME loan portfolio and higher credit loss expenses on retail loan portfolio.

 

In 12M 2022, the overall dynamics of the fee and commission income and expense was driven by the increased transactional activity as a result of the clients inflow due to changes in the operating landscape. The net fee and commission income for 12M 2022 increased by 25.8% vs. 12M 2021 due to increase in net transactional income of both legal entities and individuals (9), as well as in fees on letters of credit and guarantees issued, which was mainly propped by the increase in overall volume of letters of credit and guarantees issued.

 

Net foreign exchange gain increased by 5.9x for 12M 2022 vs. 12M 2021 mainly due to the volatility of exchange rates and interest rates, which resulted in significant growth in net dealing income.

 

Other non-interest income (10) decreased by 81.3% for 12M 2022 vs. 12M 2021 mainly due to the loss and other related expenses on disposal of subsidiaries amid the sale of subsidiary banks in Tajikistan and Russia.

 

The net insurance income (11) for 12M 2022 decreased by 50.3% year-on-year, due to increase in insurance reserve expenses on unsecured consumer loans with a borrower’s life insurance bundle.

 

The operating expenses for 12M 2022 increased by 11.7% vs. 12M 2021 mainly due to the indexation of salaries and other employee benefits starting from March 1, 2022, the employee premiums reserve accrued in 12M 2022, as well as increase in charity expenses and IT investments.

 

The cost-to-income ratio decreased to 19.0% compared to 24.1% for 12M 2021 amid higher operating income for 12M 2022.

 

 

 

 

 

 

  1. Transactional income of individuals, less transactional expenses of individuals and less loyalty program bonuses;
  2. Other non-interest income (Net (loss)/gain on financial assets and liabilities at fair value through profit or loss, net realised (loss)/gain from financial assets at fair value through other comprehensive income, share in profit of associate, income on non-banking activities, other (expense)/income and loss on disposal of subsidiaries);
  3. Insurance underwriting income (gross insurance premiums written, net change in unearned insurance premiums, ceded reinsurance share) less insurance claims incurred, net of reinsurance (insurance payments, insurance reserves expenses, commissions to agents).

Statement of financial position review

KZT mln

 

 

31-Dec-22

 

30- Sep

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière